Shopping Cart
- Remove All
- Your shopping cart is currently empty
Lenzilumab (KB 003) is a humanized monoclonal antibody targeting CSF2/GM-CSF, with applications in COVID-19 treatment and research on chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML) [1] [2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $385 | 7-10 days | |
5 mg | $1,150 | 7-10 days | |
10 mg | $1,730 | 7-10 days | |
25 mg | $2,940 | 7-10 days |
Description | Lenzilumab (KB 003) is a humanized monoclonal antibody targeting CSF2/GM-CSF, with applications in COVID-19 treatment and research on chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML) [1] [2]. |
Cas No. | 1229575-09-0 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.